Skip to content

Faeth Therapeutics, Inc.

FTH Nasdaq SEC CIK 1829802

Follow Faeth Therapeutics Weekly email: filings, results, news

News

2 stories filed under Faeth Therapeutics

Markets

Thread · 2 stories

Faeth Therapeutics stock hits 52-week high at 40.89 USD

Markets 20 d ago

Faeth Therapeutics: PI3K Pathway Inhibitor With Key Data Catalyst In Play Intrigues

Markets 44 d ago

Profile

Headquarters: AUSTIN, TX, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator